References
  1. Chang D, Lin M, Wei L, Xie L, Zhu G, Dela Cruz CS, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA 2020; 323,11:1092-1093.
  2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patientswith 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; 323(11):1061-1069.
  3. Wenzhong Liu, Hualan Li. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. DOI: 10.26434/chemrxiv.12120912.
  4. Mast AE, Blinder MA, Dietzen DJ. Reticulocyte hemoglobin content. Am J Hematol. 2008; 83:307-310.
  5. Eguchi A, Tsuchiya K, Tsukada M, Nitta K. Clinical usefulness of reticulocyte hemoglobin equivalent (RET-He) in patients at the pre-dialysis stage and in patients on peritoneal dialysis. Japanese Journal of Nephrology. 2010; 52(2):132-140.
  6. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002; 48:1066-1076.
  7. Fairbanks VF, Beutler E. Iron Deficiency. In: Beutler E, Lichtman MA, Coller BS, et al. Editors. Williams Hematology, Sixth edition. New York: McGraw-Hill; 2001. Pp: 447-470.
  8. Kim JM, Ihm CH, Kim HJ. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients. Int J Lab Hematol. 2008; 30:46-52.
  9. Bellmann-Weiler R, Lanser L, Barket R, Rangger L, Schapfl A, Schaber M, et al. Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection. J. Clin. Med. 2020; 9:2429: 1-11.
  10. Eskeland B, Baerheim A, Ulvik R, Hunskaar S. Influence of mild infections on iron status parameters in women of reproductive age. Scand J Prim HealthCare. 2002; 20:50–56.
  11. Punnonen K, Irjala K, Rajamäki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997; 89:1052–1057.
  12. Edeas M, Saleh J, Peyssonnaux C. Iron: innocent by stander or vicious culprit in COVID-19 pathogenesis? Int J InfectDis. Int J InfectDis. 2020; 97: 303–305.
  13. Drakesmith H, Prentice A. Viral infection and iron metabolism. Nat. Rev. Microbiol. 2008; 6:541-552.
  14. Taneri PE, Gómez‑Ochoa SA, Llanaj E, Raguindin PF, Rojas LZ, Roa‑Díaz ZM, et al. Anemia and iron metabolism in COVID-19: a systematic review and meta-analysis. European Journal of Epidemiology. 202; 35: 763–773.
  15. Huang Y, Tu M, Wang S, Chen S, Zhou W, Chen D, et al. Clinical characteristics of laboratory confirmed positive cases of SARS-CoV-2 infection in Wuhan, China: A retrospective single center analysis. Travel Medicine and Infectious Disease 36 (2020) 101606. https://doi.org/10.1016/j.tmaid.2020.101606.
  16. Alipour R, Hashemi SH, Mikaeili F. Serum iron level in patients with COVID-19: a case report study. Int J Res Med Sci. 2020 Jul; 8(7): 2658-2662.
  17. Cavezzi A, Troiani E, Corrao S. COVID-19: hemoglobin, iron, and hypoxia beyond inflammation. A narrative review. Clinics and Practice. 2020; 10:1271:24-30.
  18. Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020; 146(1):110–8.
  19. Shah A, Frost JN, Aaron L, Donovan K, Drakesmith H. Collaborators Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19. Crit Care. 2020;24(1):320. https ://doi.org/10.1186/s1305 4-020-03051-w.